Evaluation of the efficacy and tolerance of Soyfem in women in the early menopausal period
Journal Title: Przegląd Menopauzalny - Year 2006, Vol 25, Issue 3
Abstract
Objective: The evaluation of efficacy and tolerance of using Soyfem in women in the early postmenopausal period treated with the drug for 12 months. Design: 71 women in the early postmenopausal period were randomized and assigned to one of three groups: group I treated with 2 tablets of placebo twice a day (n=23); group II treated with 1 tablet of the Soyfem preparation and 1 tablet of placebo twice a day (n=26; 200 mg of extract, i.e. 52 mg of genistein); group III treated with 2 tablets of the Soyfem preparation twice a day (n=22; 400 mg of extract, i.e. 104 mg of genistein). The frequency and intensity of menopausal signs were evaluated using the Kupperman test every 30 days for 12 months. Statistical analyses of evaluated parameters were made using Statistica PC, StatSoft. Results: Treatment with the Soyfem preparation leads to a significant decrease of the frequency and intensity of menopausal signs after 3 months of therapy with the higher drug dosage (p
Authors and Affiliations
Stanisław Stanosz, Ewa Puk, Włodzimierz Grobelny, Małgorzata Stanosz, Agnieszka Kazikowska
Influence of six months' transdermal 17β-oestradiol administration combined with oral medroxyprogesterone or oral simvastatin treatment on glycaemia and insulinaemia in postmenopausal women with normal and impaired tolerance
Aim of study: Comparison between influence of transdermal continuous 17β-oestradiol combined with oral medroxyprogesterone (HRT) and oral simvastatin treatment on glycaemia and insulinaemia in postmenopausal women with...
Preoperative period as a stressful situation for women
Aim of study: The aim of the study was to verify, whether and how far preoperative period was stressful situation for women hospitalized in gynaecology department. Materials and methods: The study was carried out among...
Progress in ovarian cancer diagnostics
Ovarian cancer is characterized by lack of early symptoms, presentation at an advanced stage, and poor prognosis. The molecular events leading to the development and progression of ovarian carcinoma are not completely...
Wpływ przezskórnej terapii hormonalnej na ryzyko zakrzepowo-zatorowe u kobiet w okresie menopauzy
Niniejszy artykuł stanowi przegląd aktualnych doniesień na temat wpływu przezskórnej terapii hormonalnej (HT) na elementy hemostazy odpowiedzialne za wystąpienie powikłań zakrzepowo-zatorowych – jednych z groźniejszych...
Postępy w diagnostyce raka jajnika
Rak jajnika od lat jest przedmiotem szczególnego zainteresowania zarówno klinicystów, jak i naukowców. Jest ono wynikiem ciągle naszej niewielkiej wiedzy w zakresie szeroko rozumianej biologii tego nowotworu. Skuteczna...